Stand 2-142 at the Riyadh International Convention & Exhibition Centre will get busy on Sunday, when Emirates Biotech opens its booth at Saudi Plastics & Petrochem 2026. The Dubai-based firm arrives with a newly hired Saudi sales manager and a specific pitch: plant-based polymers for a kingdom chasing sustainability targets.
Hashim Alfulful joined Emirates Biotech recently as Sales Development Manager covering Saudi Arabia, Bahrain, and Kuwait.
His appointment signals the company’s intent to secure ground in a market where Vision 2030—Saudi Arabia’s economic diversification blueprint—has elevated demand for materials that don’t rely on fossil fuels. The four-day exhibition, running from 21-24 June, marks the official introduction of Emirates Biotech’s Embio PLA biopolymer range to Saudi buyers.
PLA stands for PolyLacticAcid. It’s derived from plants, which absorb carbon dioxide during growth, positioning the material as an alternative to conventional petroleum-based plastics. Emirates Biotech manufactures and markets these biopolymers across packaging, food service items, consumer goods, and 3D printing applications—sectors where Saudi Arabia’s industrial base is expanding.
The company’s Chief Commercial Officer, François de Bie, framed the Saudi market as central to the firm’s regional growth. “The Kingdom of Saudi Arabia is an exciting and fast-growing market for sustainable materials,” de Bie noted. “Biopolymers like PLA provide the Kingdom with opportunities to realize its Vision 2030 sustainability goals; PLA supports the transition toward more circular and responsible material solutions.”
The timing isn’t coincidental. Saudi Arabia has committed substantial resources to diversifying away from oil dependency, with circular economy principles embedded in national planning documents. That creates commercial openings for materials suppliers who can credibly claim environmental advantages over traditional plastics—a category that includes the thousands of tonnes of conventional polymer resins produced annually across the Gulf.
Alfulful’s role centres on customer evaluation and implementation support. “Having a dedicated presence in Saudi Arabia allows us to work closely with customers and support them in evaluating and implementing PLA solutions,” he explained. “We look forward to building strong partnerships as the market continues to demand more sustainable materials.”
Empirates Biotech isn’t alone in eyeing the Saudi opportunity. The Middle East’s biopolymers sector has attracted growing investment as regional governments impose stricter environmental regulations and state-owned enterprises seek to demonstrate sustainability credentials. Yet the commercial challenge remains steep: plant-based polymers typically cost more than fossil-fuel equivalents, and buyers must be convinced that performance matches price.
The company positions its Embio PLA range as both recyclable and biodegradable—a dual claim that addresses two separate waste management pathways. Prashant Lohade, who manages sales across the UAE, Oman, and India, highlighted the material’s end-of-life characteristics. “PLA biopolymers not only offer a reduced carbon footprint, but PLA is also recyclable and biodegradable,” Lohade said. “They do not leave any microplastics in the environment.”
That absence of microplastic residue matters. Conventional plastics fragment into particles that persist in soil and water, creating contamination concerns that have drawn regulatory scrutiny worldwide. PLA’s ability to break down naturally—under specific composting conditions—offers a potential advantage, though industrial composting infrastructure in the Gulf remains limited.
Empirates Biotech describes itself as the leading PLA biopolymer manufacturer and marketer in the Middle East, operating from its UAE base. The company sits within Global Biopolymers Industries, a parent organisation focused on renewable polymer technologies. Its product portfolio spans multiple PLA grades designed for different applications, from rigid packaging to flexible films and filaments for additive manufacturing.
Visitors to the exhibition will find the Emirates Biotech team stationed in the UAE Pavilion, where the company plans demonstrations of its material properties and application case studies. The booth setup reflects a broader pattern: UAE-based firms using Saudi trade shows to establish commercial relationships in the kingdom’s expanding industrial markets.
For Emirates Biotech, the Riyadh event represents a test of whether Saudi manufacturers and converters will pay a premium for plant-based alternatives. Vision 2030 provides policy tailwinds, but purchasing decisions ultimately hinge on cost, performance, and supply reliability.
By Thursday evening, when the exhibition halls close, the company will have a clearer sense of Saudi appetite for biopolymers. Alfulful’s recent hire suggests Emirates Biotech expects that appetite to be substantial enough to justify a permanent presence across three Gulf markets.
The broader question facing the biopolymers industry in the region is whether sustainability commitments translate into actual material substitution at scale. Saudi Arabia’s chemicals sector remains dominated by petrochemical giants with entrenched supply chains and cost advantages. Displacing conventional plastics will require more than policy aspirations—it demands customers willing to switch, and infrastructure capable of handling plant-based alternatives through their full lifecycle.
Empirates Biotech’s presence in Riyadh next week offers one data point in that larger transition. Whether it becomes a commercial breakthrough or a modest foothold will depend on conversations happening across three days in a convention centre booth, where sales managers meet procurement teams and sustainability promises meet price negotiations.
